Free-cash-flow margin moved 1992 bp lower
Free-cash-flow margin changed -1992 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
24.90%→4.98%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →QCOM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
R&D / revenue moved 473 bp higher
R&D / revenue changed +473 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
21.48%→26.21%2 prior comparisons
Capital expenditure increased 68.7%
Capital expenditure changed +68.7% from the comparable as-filed period.
$294.0M→$496.0M2 prior comparisons
SBC / revenue moved 199 bp higher
SBC / revenue changed +199 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.36%→8.34%2 prior comparisons
Selling, general & administrative increased 26.6%
Selling, general & administrative changed +26.6% from the comparable as-filed period.
$771.0M→$976.0M2 prior comparisons
Debt / revenue moved 1418 bp lower
Debt / revenue changed -1418 basis points from the comparable as-filed period.
142.67%→128.49%2 prior comparisons
Capex / revenue moved 215 bp higher
Capex / revenue changed +215 basis points from the comparable as-filed period.
2.84%→4.99%2 prior comparisons
Stock-based compensation increased 25.9%
Stock-based compensation changed +25.9% from the comparable as-filed period.
$659.0M→$830.0M2 prior comparisons
Cash & equivalents decreased 16.8%
Cash & equivalents changed -16.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.4B→$4.5B4 prior comparisons
Revenue decreased 4.0%
Revenue changed -4.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$10.4B→$9.9B2 prior comparisons
Research & development increased 17.1%
Research & development changed +17.1% from the comparable as-filed period.
$2.2B→$2.6B2 prior comparisons
Net debt decreased 11.7%
Net debt changed -11.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$9.3B→$8.2B4 prior comparisons
Operating cash-flow margin moved 1777 bp lower
Operating cash-flow margin changed -1777 basis points from the comparable as-filed period.
27.74%→9.96%2 prior comparisons
Operating cash flow / net income decreased 54.1%
Operating cash flow / net income changed -54.1% from the comparable as-filed period.
1.08→0.52 prior comparisons
Current assets decreased 7.7%
Current assets changed -7.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$24.9B→$23.0B4 prior comparisons
Shares outstanding decreased 2.7%
Shares outstanding changed -2.7% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
1,079,000,000→1,050,000,0008 prior comparisons
Cash / debt moved 137 bp lower
Cash / debt changed -137 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
36.84%→35.47%4 prior comparisons
Total assets increased 4.6%
Total assets changed +4.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$54.9B→$57.4B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.